Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685879 · ClinicalTrials.gov registry record · NA
Glycemic Response to High Amylose Rice
A NA study of Diabetes Treatment (Pilot Study), sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01685879 is a NA study of Diabetes Treatment (Pilot Study) that has completed, run by University of Hawaii. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01685879, a NA study of Diabetes Treatment (Pilot Study), has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Certain types of rice have more dietary fiber than others. This type of rice is known a "high amylose rice." This study hypothesizes that high-amylose rice, will decrease blood glucose and insulin responses after consumption compared to conventional rice in healthy adults, ages 18-40. Eighteen healthy men and women will participate in this study. This study will determine how high blood glucose and insulin values rise after eating a portion of rice. This study will also evaluate hunger ratings after consuming rice. The results of this study will help researchers better understand how diet can influence diabetes management.
Conditions Studied
Interventions
- OTHER Rice
- OTHER Glucose Beverage
Study Locations (1)
Hawaii
- University of Hawaii at Manoa - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01685879
The ClinicalTrials.gov registry entry for NCT01685879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Treatment (Pilot Study) appearing as the primary indexed condition, and to 2 interventions - of which Rice is the first listed.
NCT01685879 reports 1 study location spanning 1 distinct geographic area - top geographies include Hawaii.
Frequently Asked Questions
What is clinical trial NCT01685879 about?
NCT01685879 is a clinical study titled "Glycemic Response to High Amylose Rice". Certain types of rice have more dietary fiber than others. This type of rice is known a "high amylose rice." This study hypothesizes that high-amylose rice, will decrease blood glucose and insulin responses after consumption compared to conventional rice in healthy adults, ages 18-40. Eighteen healt...
What is the current status of trial NCT01685879?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2012-10. Estimated completion is 2014-01.
What conditions does trial NCT01685879 study?
This clinical trial studies the following conditions: Diabetes Treatment (Pilot Study).
What interventions are being tested in trial NCT01685879?
The interventions under investigation include: Rice (OTHER), Glucose Beverage (OTHER).
Who is sponsoring clinical trial NCT01685879?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01685879 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.